- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/06 - 1,2,3-TriazolesHydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
Patent holdings for IPC class C07D 249/06
Total number of patents in this class: 675
10-year publication summary
|
57
|
43
|
59
|
45
|
46
|
52
|
36
|
38
|
30
|
14
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4815 |
25 |
| Centre National de La Recherche Scientifique | 10895 |
16 |
| F. Hoffmann-La Roche AG | 7841 |
11 |
| Janssen Pharmaceutica N.V. | 3226 |
11 |
| Institut Curie | 609 |
10 |
| Universite de Montpellier | 1031 |
10 |
| The Regents of the University of California | 20587 |
9 |
| Bayer Cropscience AG | 1882 |
9 |
| Siemens Medical Solutions USA, Inc. | 1470 |
8 |
| Roche Diagnostics Operations, Inc. | 1509 |
7 |
| Imago Biosciences, Inc. | 40 |
7 |
| The University of Queensland | 663 |
7 |
| Sigilon Therapeutics, Inc. | 111 |
7 |
| E. I. du Pont de Nemours and Company | 3652 |
6 |
| Arcus Biosciences, Inc. | 162 |
6 |
| FMC Corporation | 813 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 177 |
6 |
| The Research Foundation for The State University of New York | 1717 |
6 |
| Yale University | 2493 |
6 |
| Pfizer Inc. | 3370 |
5 |
| Other owners | 497 |